Regenxbio RGNX Royalty Monetization Liabilities Noncurrent
Royalty Monetization Liabilities Noncurrent at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept rgnx:RoyaltyMonetizationLiabilitiesNoncurrent.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's royalty monetization liabilities noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's royalty monetization liabilities noncurrent?
- Regenxbio (RGNX) reported royalty monetization liabilities noncurrent of $163.11M in Q1 2026.
- What does royalty monetization liabilities noncurrent mean?
- This represents the long-term portion of financial obligations resulting from the upfront monetization of future royalty income, due beyond the next twelve months. It indicates the extent to which the company has leveraged its intellectual property assets to secure non-dilutive capital for research and development or operational needs. Investors use this to understand the long-term debt burden and the degree to which future revenue streams are encumbered by past financing activities.